Mouse Diazepam Binding Inhibitor (DBI) ELISA Kit

The kit enables quantitative measurement of endogenous Diazepam Binding Inhibitor, also referred to as acyl-CoA-binding protein (ACBP), in murine specimen matrices. Built around antibody pairs that recognize epitopes specific to the mouse DBI sequence, the workflow uses a microplate pre-coated with capture antibody, sequential incubations with standards and samples, and a substrate reaction that produces a measurable signal proportional to DBI concentration. Researchers studying GABA-A receptor pharmacology, neuropeptide signaling, lipid metabolism, or stress-related physiology can apply this in vitro ELISA to monitor DBI levels across experimental cohorts.

Each kit contains reagents sufficient for 96 assays, including a pre-coated plate, reference standard, detection antibody, and chromogenic substrate. The protocol accommodates standard laboratory incubation schedules and routine immunoassay workflows in research-use settings.

Assay Genie supplies this reagent set for applications spanning neuroscience, endocrinology, and metabolic disease investigation. Mouse DBI is a small conserved polypeptide implicated in modulation of GABA-A receptor activity, intracellular acyl-CoA buffering during fatty acid metabolism, and extracellular signaling pathways, making accurate quantification valuable across multiple basic-research programs.